| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Back pain: a target for reducing hospital admissions?
|
Machado, Gustavo C
|
|
|
5 |
11 |
p. e643-e645
|
artikel
|
| 2 |
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine
|
Lescoat, Alain
|
|
|
5 |
11 |
p. e683-e694
|
artikel
|
| 3 |
Embracing holistic management in SLE
|
The Lancet Rheumatology,
|
|
|
5 |
11 |
p. e639
|
artikel
|
| 4 |
Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
|
|
|
|
5 |
11 |
p. e670-e682
|
artikel
|
| 5 |
Ngozi Chiejina: perseverance in the face of adversity
|
Morgan, Jules
|
|
|
5 |
11 |
p. e647
|
artikel
|
| 6 |
Polychondritis in a child
|
Gu, Yudan
|
|
|
5 |
11 |
p. e695-e696
|
artikel
|
| 7 |
Research in Brief
|
Thorley, Jennifer
|
|
|
5 |
11 |
p. e646
|
artikel
|
| 8 |
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial
|
Distler, Oliver
|
|
|
5 |
11 |
p. e660-e669
|
artikel
|
| 9 |
Riociguat in systemic sclerosis: challenges in crossing the bridge from bench to bedside
|
de Vries-Bouwstra, Jeska K
|
|
|
5 |
11 |
p. e641-e643
|
artikel
|
| 10 |
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials
|
Rivellese, Felice
|
|
|
5 |
11 |
p. e648-e659
|
artikel
|
| 11 |
Synovial tissue for personalised medicine in rheumatoid arthritis: hype or hope?
|
van der Helm-van Mil, Annette H
|
|
|
5 |
11 |
p. e640-e641
|
artikel
|
Tijdschrift beschrijving